Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia

NCT00002549 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1520

Enrollment

NETWORK

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: filgrastim
DRUG: busulfan
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: daunorubicin hydrochloride
DRUG: etoposide
DRUG: idarubicin
DRUG: mesna
DRUG: mitoxantrone hydrochloride
PROCEDURE: allogeneic bone marrow transplantation
PROCEDURE: autologous bone marrow transplantation
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: radiation therapy

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC